Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
18,300
Views
95
CrossRef citations to date
0
Altmetric
Review

Immune responses during COVID-19 infection

Cléa Melenottea Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;c Infectious Diseases, Aix-Marseille Université, IRD, APHM, MEPHI, Marseille, France;d Infectious Diseases, IHU-Méditerranée Infection, Marseille, FranceCorrespondence[email protected]
View further author information
,
Aymeric Silvina Immunology, Gustave Roussy, Villejuif, FranceView further author information
,
Anne-Gaëlle Goubeta Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;e Immunology, Institut National de la Santé Et de la Recherche Médicale (INSERM), U1015 Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceView further author information
,
Imran Lahmara Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;e Immunology, Institut National de la Santé Et de la Recherche Médicale (INSERM), U1015 Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceView further author information
,
Agathe Dubuissona Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;e Immunology, Institut National de la Santé Et de la Recherche Médicale (INSERM), U1015 Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceView further author information
,
Alimuddin Zumlag Department of Infection, Division of Infection and Immunity, University College London, National Institute for Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UKView further author information
,
Didier Raoultb Gustave Roussy, Université Paris-Saclay, Villejuif, France;c Infectious Diseases, Aix-Marseille Université, IRD, APHM, MEPHI, Marseille, FranceView further author information
,
Mansouria Meradh Service de Urgences et de Permanence des Soins, Gustave Roussy Cancer Campus Grand Paris, Villejuif, FranceView further author information
,
Bertrand Gachota Immunology, Gustave Roussy, Villejuif, FranceView further author information
,
Clémence Hénona Immunology, Gustave Roussy, Villejuif, FranceView further author information
,
Eric Solarya Immunology, Gustave Roussy, Villejuif, FranceView further author information
,
Michaela Fontenayi INSERM U1016, Centre National Recherche Scientifique (CNRS) UMR8104, Institut Cochin, Université de Paris, Paris, FranceView further author information
,
Fabrice Andréa Immunology, Gustave Roussy, Villejuif, FranceView further author information
,
Markus Maeurerj Immunosurgery, Immunotherapy Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal;k Med Clinic, University of Mainz, Mayence, GermanyView further author information
,
Giuseppe Ippolitol Dipartimento di Epidemiologia Ricerca Pre-Clinica e Diagnostica Avanzata, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S., Rome, ItalyView further author information
,
Mauro Piacentinim Department of Biology, University of Rome “Tor Vergata”, Rome, Italy;n Infectious Diseases Department, National Institute for Infectious Disease IRCCS “Lazzaro Spallanzani”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-2919-1296View further author information
ORCID Icon,
Fu-Sheng Wango National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaView further author information
,
Florent Ginhouxp Singapore Immunology Network, Agency for Science, Technology and Research, Singapore;q Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China;r Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, SingaporeView further author information
,
Aurélien Marabellec Infectious Diseases, Aix-Marseille Université, IRD, APHM, MEPHI, Marseille, FranceView further author information
,
Guido Kroemers Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France;t Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France;u Pôle de Biologie,Pathologie – PUI – Hygiène, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;v Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden;w Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-9334-4405View further author information
ORCID Icon,
Lisa Derosaa Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;e Immunology, Institut National de la Santé Et de la Recherche Médicale (INSERM), U1015 Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceView further author information
&
Laurence Zitvogela Immunology, Gustave Roussy, Villejuif, France;b Gustave Roussy, Université Paris-Saclay, Villejuif, France;e Immunology, Institut National de la Santé Et de la Recherche Médicale (INSERM), U1015 Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;w Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-1596-0998View further author information
ORCID Icon show all
Article: 1807836 | Received 29 May 2020, Accepted 05 Aug 2020, Published online: 25 Aug 2020

Citations (95)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Mrinal K Ghosh, Sunny Kumar, Kirat K Ganguly, Pratyay Ghosh, Shaheda Tabassum, Bhaskar Basu & Malini Basu. (2023) Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic Landscape. Epigenomics 15:4, pages 227-248.
Read now
T Karuna, Rahul Garg, Shweta Kumar, Gyanendra Singh, Lakshmi Prasad, Kawal Krishen Pandita, Abhijit Pakhare, Saurabh Saigal, Alkesh Kumar Khurana, Rajnish Joshi, Kamini Walia & Sagar Khadanga. (2022) Clinico–Epidemio-Microbiological Exploratory Review Among COVID-19 Patients with Secondary Infection in Central India. Infection and Drug Resistance 15, pages 1667-1676.
Read now
Hongran Li, Tong Jiao, Peirong Wang, Juanjuan An, Gang Deng, Lei Sun & Jinchun Dong. (2021) Key Points of Technical Review for the Registration of Sars-Cov-2 Nucleic Acid Tests in China. Bioanalysis 13:23, pages 1731-1741.
Read now
Shashank Shekhar Gautam, C.S Gautam, Vivek Kumar Garg & Harmanjit Singh. (2020) Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection. Expert Review of Clinical Pharmacology 13:11, pages 1183-1190.
Read now
Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, Pascale Gaussem, Syrine Ellouze, Georges Jourdi, Eric Solary, Michaela Fontenay, David M. Smadja & Guido Kroemer. (2020) No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. OncoImmunology 9:1.
Read now
Fernanda Pohl-Guimarães, Lan B. Hoang-Minh & Duane A. Mitchell. (2020) RNA-electroporated T cells for cancer immunotherapy. OncoImmunology 9:1.
Read now
Nadja Salomon, Fulvia Vascotto, Abderaouf Selmi, Mathias Vormehr, Juliane Quinkhardt, Thomas Bukur, Barbara Schrörs, Martin Löewer, Mustafa Diken, Özlem Türeci, Ugur Sahin & Sebastian Kreiter. (2020) A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. OncoImmunology 9:1.
Read now

Articles from other publishers (88)

Jacquelynne Cervantes-Torres, Carlos Cabello-Gutiérrez, Dolores-Adriana Ayón-Núñez, Gloria Soldevila, Roxana Olguin-Alor, Georgina Diaz, Gonzalo Acero, René Segura-Velázquez, Leonor Huerta, Isabel Gracia-Mora, Laura Cobos, Mayra Pérez-Tapia, Juan C. Almagro, Francisco Suárez-Güemes, Raúl J. Bobes, Gladis Fragoso, Edda Sciutto & Juan Pedro Laclette. (2024) Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice. Applied Microbiology and Biotechnology 108:1.
Crossref
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, Mahdieh Abbasalizad Farhangi, Mohammad Bagherniya, Gholamreza Askari, Basil D. Roufogalis, Neal M. Davies & Amirhossein Sahebkar. (2024) Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy. Pharmacological Reports.
Crossref
João Pedro Pereira Passos, Nayara Silva do Vale, Raimundo Wagner de Souza Aguiar, Ilsamar Mendes Soares, Andressa Ribeiro de Sousa & Sergio Donizeti Ascencio. (2024) Covid-19 provocou mais de 12 mil mortes súbitas no Brasil nos primeiros três anos de pandemia: estudo epidemiológico, observacional e descritivo. Cuadernos de Educación y Desarrollo 16:3, pages e3643.
Crossref
Thomas Lafon, Nicolas Chapuis, Estelle Guerin, Thomas Daix, Marcela Otranto, Ahmed Boumediene, Robin Jeannet, Michaela Fontenay, Henri Hani Karam, Philippe Vignon, Guillaume Monneret, Bruno François, Jean-Philippe Jais & Jean Feuillard. (2024) Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in emergency departments. Journal of Leukocyte Biology.
Crossref
Artem Rubinstein, Igor Kudryavtsev, Annа Malkova, Jennet Mammedova, Dmitry Isakov, Irina Isakova-Sivak, Dmitry Kudlay & Anna Starshinova. (2023) Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients. Frontiers in Medicine 10.
Crossref
Zahra Bagheri-Hosseinabadi, Ali Pirsadeghi, Hamid Ostadebrahimi, Gholamhossein Taghipour Khaje Sharifi & Mitra Abbasifard. (2023) Correlation of iron and related factors with disease severity and outcomes and mortality of patients with Coronavirus disease 2019. Journal of Trace Elements in Medicine and Biology 80, pages 127285.
Crossref
Nayab Batool Rizvi, Hassam Farooq, Qaiser Alam Khan, Muhammad Zeeshan Rana, Sehrish Zaffar, Muhammad Shahid & Nazim Hussain. (2023) Comparative Analysis of IgG Antibody Titers Induced by Three Different SARS-COV-2 Vaccines in Healthy Adults of Pakistan. Current Microbiology 80:12.
Crossref
Sarah L Braunstein, Amanda Wahnich & Rachael Lazar. (2023) COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. The Journal of Infectious Diseases 228:11, pages 1571-1582.
Crossref
Sonali Tayal & Sonika Bhatnagar. (2023) Role of molecular mimicry in the SARS-CoV-2-human interactome for pathogenesis of cardiovascular diseases: An update to ImitateDB. Computational Biology and Chemistry 106, pages 107919.
Crossref
I. V. Alekseenko, R. G. Vasilov, L. G. Kondratyeva, S. V. Kostrov, I. P. Chernov & E. D. Sverdlov. (2023) The Cellular and Epigenetic Aspects of Trained Immunity and Prospects for Creation of Universal Vaccines on the Eve of More Frequent Pandemics. Russian Journal of Genetics 59:9, pages 851-868.
Crossref
Trevor R. Norman. (2023) Treatment of Brain Fog of Long COVID Syndrome: A Hypothesis. Psychiatry International 4:3, pages 242-245.
Crossref
Stanislav Polozov, Lourdes Cruz-Garcia, Grainne O'Brien, Veronika Goriacha, Farah Nasser, Penelope Jeggo, Serge Candéias & Christophe Badie. (2023) Deficient Radiation Transcription Response in COVID-19 Patients. Advances in Radiation Oncology 8:4, pages 101215.
Crossref
Guo‐hua Zhu, Lu Liu, Xi‐xi Huang, Da‐jin Li, Yi‐zhun Zhu, Xin Lu & Mei‐rong Du. (2022) The risk of intrauterine exposure to SARS‐CoV‐2 in female COVID‐19 patients: A comprehensive review. American Journal of Reproductive Immunology 89:6.
Crossref
Erika Asperges, Giuseppe Albi, Valentina Zuccaro, Margherita Sambo, Teresa C. Pieri, Matteo Calia, Marta Colaneri, Laura Maiocchi, Federica Melazzini, Angioletta Lasagna, Andrea Peri, Francesco Mojoli, Paolo Sacchi & Raffaele Bruno. (2023) Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study. Infectious Diseases and Therapy 12:6, pages 1625-1640.
Crossref
Amir Hossein Mansourabadi, Azin Aghamajidi, Maryam Dorfaki, Fatemeh Keshavarz, Zahra Shafeghat, Ali Moazzeni, Fahimeh Lavi Arab, Arezoo Rajabian, Mona Roozbehani, Reza Falak, Fatemeh Faraji & Reza Jafari. (2023) B lymphocytes in COVID-19: a tale of harmony and discordance. Archives of Virology 168:5.
Crossref
Concetta Meo, Giuseppe Palma, Francesca Bruzzese, Alfredo Budillon, Claudio Napoli & Filomena de Nigris. (2023) Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment. Journal of Translational Medicine 21:1.
Crossref
Kexin Jia, Yijie Li, Tiegang Liu, Xiaohong Gu & Xiaojiaoyang Li. (2023) New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches. Chinese Herbal Medicines 15:2, pages 157-168.
Crossref
Mélanie Bourgin, Sylvère Durand & Guido Kroemer. (2023) Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics. Metabolites 13:3, pages 342.
Crossref
A. Razi, A. Azimian, R. Arezumand, A. Solati & H. N. Ahmadabad. (2023) Associations between serum levels of C3, C4, and total classical complement activity in COVID-19 patients at the time of admission and clinical outcome. Russian Journal of Infection and Immunity 12:5, pages 869-874.
Crossref
Irina Zh. Shubina, Irina O. Chikileva & Nikolay Yu. Sokolov. 2023. Cancer Treatment: An Interdisciplinary Approach. Cancer Treatment: An Interdisciplinary Approach 251 266 .
Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Franco Wing Tak Cheng, Ching Lung Cheung, Celine Sze Ling Chui, Xue Li, Eric Yuk Fai Wan, Carlos King Ho Wong, Ivan Fan Ngai Hung, Chak Sing Lau, Ian Chi Kei Wong & Esther Wai Yin Chan. (2022) Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic. npj Vaccines 7:1.
Crossref
Huilei Zhao, Shanshan Huang, Shan Huang, Fuwei Liu, Wen Shao, Kaibo Mei, Jianyong Ma, Yuan Jiang, Jingfeng Wan, Wengen Zhu, Peng Yu & Xiao Liu. (2022) Prevalence of NSAID use among people with COVID‐19 and the association with COVID‐19‐related outcomes: Systematic review and meta‐analysis. British Journal of Clinical Pharmacology 88:12, pages 5113-5127.
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) Cellular immune states in SARS-CoV-2-induced disease. Frontiers in Immunology 13.
Crossref
Awadalkareem Adam, Qing Shi, Binbin Wang, Jing Zou, Junhua Mai, Samantha R. Osman, Wenzhe Wu, Xuping Xie, Patricia V Aguilar, Xiaoyong Bao, Pei-Yong Shi, Haifa Shen & Tian Wang. (2022) A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine. Translational Research 249, pages 13-27.
Crossref
Sarra Melayah, Amani Mankaï, Malek Jemni, Arij Ben Chaben, Mariam Ghozzi, Asma Ben Abdelkrim, Kousay Ach, Nadia Ghariani, Mohamed Denguezli, Wafa Benzarti, Mohamed Benzarti, Salma Melayah, Walid Naija & Ibtissem Ghedira. (2022) Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19. Arab Journal of Gastroenterology 23:4, pages 241-245.
Crossref
Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, Nicola Scichilone, Carmela Picone, Lydia Giannitrapani, Francesco Dieli & Serena Meraviglia. (2022) Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins. Cells 11:21, pages 3449.
Crossref
Sumanashree Mallappa, Arti Khatri, Gayatri BN & Padmaja Kulkarni. (2022) A Retrospective Analysis of the Importance of Biochemical and Hematological Parameters for Mortality Prediction in COVID-19 Cases. Cureus.
Crossref
Shubhangini Tiwari, Neelam Yadav & Sarika Singh. (2022) COVID-19 and Parkinson’s Disease: Possible Links in Pathology and Therapeutics. Neurotoxicity Research 40:5, pages 1586-1596.
Crossref
Adriana M. Carlucci, Camila E. Antonelli, Juan C. Ermocida, Sofía C. Raventos & Aída E. Sterin Prync. (2022) Aportes de la biotecnología en el diagnóstico de COVID-19. Revista del Hospital Italiano de Buenos Aires 42:3, pages 143-151.
Crossref
Chanchan Xiao, Jun Su, Chanjuan Zhang, Boya Huang, Lipeng Mao, Zhiyao Ren, Weibin Bai, Huayu Li, Guomin Lei, Jingshan Zheng, Guobing Chen, Xiaofeng Liang & Congling Qiu. (2022) Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains. Viruses 14:9, pages 2016.
Crossref
Qiaoyu He, Yumeng Shi, Hong Xing, Qian Tang, Jing Liu, Chunxia Li, Han Zhang, Boli Zhang, Junhua Zhang & Xiaopeng Chen. (2022) Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats. Frontiers in Pharmacology 13.
Crossref
Roberta TUTINO, Luca BONARIOL, Ezio CARATOZZOLO & Marco MASSANI. (2022) Biliary complication and spontaneous hemoperitoneum in a coinfected CMV-CoV-2 oncologic patient submitted to major biliary surgery. Chirurgia 35:3.
Crossref
Anjali Yadav, Neha Rastogi, K. Upasana, Sunisha Arora, Dhwanee Thakkar & Satya Prakash Yadav. (2022) Milder COVID-19 in children with inborn errors of immunity. Pediatric Hematology Oncology Journal 7:3, pages 90-91.
Crossref
Shaodi Ma, Wanying Su, Chenyu Sun, Scott Lowe, Zhen Zhou, Haixia Liu, Guangbo Qu, Weihang Xia, Peng Xie, Birong Wu, Juan Gao, Linya Feng & Yehuan Sun. (2022) Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis. European Journal of Clinical Pharmacology 78:9, pages 1403-1420.
Crossref
Qianhui Hua, Hangjie Zhang, Pingping Yao, Nani Xu, Yisheng Sun, Hangjing Lu, Fang Xu, Yuting Liao, Juan Yang, Haiyan Mao, Yanjun Zhang, Hanping Zhu, Xiaowei Hu, Huakun Lv & Jianmin Jiang. (2022) Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study. Frontiers in Immunology 13.
Crossref
Olga Kalinina, Alexey Golovkin, Ekaterina Zaikova, Arthur Aquino, Vadim Bezrukikh, Olesya Melnik, Elena Vasilieva, Tatiana Karonova, Igor Kudryavtsev & Evgeny Shlyakhto. (2022) Cytokine Storm Signature in Patients with Moderate and Severe COVID-19. International Journal of Molecular Sciences 23:16, pages 8879.
Crossref
E. A. Pogodina, I. Zh. Shubina, A. V. Lobov, P. I. Ivanova & N. Yu. Sokolov. (2022) Antitumor immunotherapy and COVID-19 in cancer patients. Russian Journal of Biotherapy 21:2, pages 10-18.
Crossref
Mariem Gdoura, Raoua Touati, Sana Kalthoum, Rania Ben Slama, Nouel Fatnassi, Mehdi Mrad, Lamia Ammari, Nozha Brahmi, Amira Ben Jazia, Nahed Hogga, Henda Triki & Sondes Haddad-Boubaker. (2022) Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming in silico Hypothesis. Frontiers in Medicine 9.
Crossref
Rebeca Viurcos-Sanabria, Aarón N. Manjarrez-Reyna, Helena Solleiro-Villavicencio, Salma A. Rizo-Téllez, Lucía A. Méndez-García, Victoria Viurcos-Sanabria, Jacquelina González-Sanabria, América Arroyo-Valerio, José D. Carrillo-Ruíz, Antonio González-Chávez, Jose I. León-Pedroza, Raúl Flores-Mejía, Octavio Rodríguez-Cortés & Galileo Escobedo. (2022) In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19. Frontiers in Immunology 13.
Crossref
An-Ran Shen, Xiao-Xiao Jin, Tao-Tao Tang, Yan Ding, Xiao-Tao Liu, Xin Zhong, Yan-Dan Wu, Xue-Lian Han, Guang-Yu Zhao, Chuan-Lai Shen, Lin-Li Lv & Bi-Cheng Liu. (2022) Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice. International Journal of Nanomedicine Volume 17, pages 3325-3341.
Crossref
Vítor João Pereira Domingues Martinho. 2022. Handbook of Research on Digital Innovation and Networking in Post-COVID-19 Organizations. Handbook of Research on Digital Innovation and Networking in Post-COVID-19 Organizations 444 469 .
Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Bogusz Aksak-Wąs, Karol Serwin, Zenon Czajkowski, Ewelina Grywalska, Izabela Korona-Głowniak, Jacek Roliński & Miłosz Parczewski. (2022) Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity. Cells 11:12, pages 1978.
Crossref
Stefan Pilz, Verena Theiler-Schwetz, Christian Trummer, Robert Krause & John P.A. Ioannidis. (2022) SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity. Environmental Research 209, pages 112911.
Crossref
Maroua Slouma, Takoua Mhemli, Maissa Abbes, Wafa Triki, Rim Dhahri, Leila Metoui, Imen Gharsallah & Bassem Louzir. (2022) Rheumatoid arthritis occurring after coronavirus disease 2019 (COVID-19) infection: Case based review. The Egyptian Rheumatologist 44:3, pages 275-278.
Crossref
Sissy Therese Sonnleitner, Martina Prelog, Bianca Jansen, Chantal Rodgarkia‐Dara, Sarah Gietl, Carmen Maria Schönegger, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Giovanni Almanzar, Hanna Jury, Tom Loney, Alexander Tichy, Norbert Nowotny & Gernot Walder. (2021) Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients. Transboundary and Emerging Diseases 69:3, pages 1596-1605.
Crossref
Barik A. Salih. (2022) The effectiveness of the immune responses to SARS-CoV-2. Reviews in Medical Microbiology 33:2, pages 92-99.
Crossref
Maggie L. BartlettSan SuwanmaneeNadine Peart Akindele, Shristi GhimireAndy K.P. ChanChenxu GuoStephen J. GouldAndrea L. CoxDiane E. Griffin. (2022) Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19. Viral Immunology 35:3, pages 259-272.
Crossref
Shirin Assar, Mehran Pournazari, Parviz Soufivand & Dena Mohamadzadeh. (2022) Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review. The Egyptian Rheumatologist 44:2, pages 145-149.
Crossref
Pierre Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Tredan, Thomas Bachelot, Isabelle Ray-Coquard, Bruno Russias, Marie-Line Fournier, Benedicte Mastroianni, Virginie Avrillon, Anne-Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Perol & Jean-Yves Blay. (2022) Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients. European Journal of Cancer 165, pages 174-183.
Crossref
Hasan Fallah Huseini, Mohammadreza Gholibeikian, Majid Shohrati, Afsaneh Kaffash, Ali Taheri, Hojatolah Khajepour, Mehdi Raei, Saeed Kianbakht, Amena Fallah Hosseini, Majid Ghorbani Nohooji & Reza Mohtashami. (2022) Effects of Imfluna, an Iranian traditional polyherbal medicine, on COVID-19 symptoms: A randomized, double-blind and placebo-controlled clinical trial. Journal of Medicinal Plants 21:81, pages 51-66.
Crossref
Anna Liu, Janet Raja xavier, Yogesh Singh, Sara Y. Brucker & Madhuri S. Salker. (2022) Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Frontiers in Global Women's Health 3.
Crossref
Jaafar El Karkri, Fatima Boudchich, Vitaly Volpert & Rajae Aboulaich. (2022) Stability Analysis of a Delayed Immune Response Model to Viral Infection. Differential Equations and Dynamical Systems.
Crossref
Bharath Kumar Gajjela & Ming-Ming Zhou. (2022) Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. Drug Discovery Today 27:2, pages 390-400.
Crossref
Raphaël Bonnet, Lee Mariault & Jean-François Peyron. (2022) Identification of potentially anti-COVID-19 active drugs using the connectivity MAP. PLOS ONE 17:1, pages e0262751.
Crossref
Emily Samuela Turilli, Marta Lualdi & Mauro Fasano. (2022) Looking at COVID-19 from a Systems Biology Perspective. Biomolecules 12:2, pages 188.
Crossref
Hamed Fouladseresht, Atefe Ghamar Talepoor, Nahid Eskandari, Marzieh Norouzian, Behrooz Ghezelbash, Mohammad Reza Beyranvand, Seyed Aria Nejadghaderi, Kristin Carson-Chahhoud, Ali-Asghar Kolahi & Saeid Safiri. (2022) Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Frontiers in Immunology 12.
Crossref
Sandro M. Hirabara, Tamires D. A. Serdan, Renata Gorjao, Laureane N. Masi, Tania C. Pithon-Curi, Dimas T. Covas, Rui Curi & Edison L. Durigon. (2022) SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Mary Beth Beasley. (2022) Acute lung injury—from cannabis to COVID. Modern Pathology 35, pages 1-7.
Crossref
Youwei Zhu, Zhaoyang Zhang, Jia Song, Weizhou Qian, Xiangqian Gu, Chaoyong Yang, Nan Shen, Feng Xue & Yuanjia Tang. (2021) SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene. Frontiers in Immunology 12.
Crossref
Sarah Abdelhafeez & Derek Doherty. 2021. COVID-19. COVID-19 69 85 .
Patrida Rangchaikul & Vishwanath Venketaraman. (2021) SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations. Infectious Disease Reports 13:4, pages 993-1008.
Crossref
Xavier Gabaldó-Barrios, Simona Iftimie, Anna Hernández-Aguilera, Isabel Pujol, Frederic Ballester, Luis Fernández, Sara Cladellas, Antoni Castro, Jorge Joven, Jordi Camps & Josep M Simó. (2021) Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 58:6, pages 614-621.
Crossref
Cecilia Bussolari, Diego Palumbo, Evgeni Fominsky, Pasquale Nardelli, Rebecca De Lorenzo, Giordano Vitali, Francesco De Cobelli, Patrizia Rovere-Querini & Anna Mara Scandroglio. (2021) Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019. Frontiers in Medicine 8.
Crossref
Xiaojiao Zeng, Xianghu Jiang, Liu Yang, Yunbao Pan & Yirong Li. (2021) COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes. Journal of Immunology Research 2021, pages 1-12.
Crossref
Laura Marongiu, Mihai Valache, Fabio A. Facchini & Francesca Granucci. (2021) How dendritic cells sense and respond to viral infections. Clinical Science 135:19, pages 2217-2242.
Crossref
Maryam Meskini, Mina Rezghi Rami, Parang Maroofi, Soumya Ghosh, Seyed Davar Siadat & Mojgan Sheikhpour. (2021) An Overview on the Epidemiology and Immunology of COVID-19. Journal of Infection and Public Health 14:10, pages 1284-1298.
Crossref
Abdolreza Esmaeilzadeh, Samaneh Rostami, Pegah M. Yeganeh, Safa Tahmasebi & Majid Ahmadi. (2021) Recent advances in antibody‐based immunotherapy strategies for COVID‐19. Journal of Cellular Biochemistry 122:10, pages 1389-1412.
Crossref
Mélanie Bourgin, Lisa Derosa, Carolina Alves Costa Silva, Anne-Gaëlle Goubet, Agathe Dubuisson, François-Xavier Danlos, Claudia Grajeda-Iglesias, Luigi Cerbone, Arthur Geraud, Ariane Laparra, Fanny Aprahamian, Nitharsshini Nirmalathasan, Frank Madeo, Laurence Zitvogel, Guido Kroemer & Sylvère Durand. (2021) Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients. Aging 13:17, pages 20860-20885.
Crossref
Christian A. Devaux, Cléa Melenotte, Marie-Dominique Piercecchi-Marti, Clémence Delteil & Didier Raoult. (2021) Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?. Frontiers in Medicine 8.
Crossref
Jayanta Kumar Das, Swarup Roy & Pietro Hiram Guzzi. (2021) Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis. Infection, Genetics and Evolution 93, pages 104921.
Crossref
Roberta Tutino, Luca Bonariol, Ezio Caratozzolo & Marco Massani. (2021) Massive late postoperative bleeding after abdominal surgery in a haematologic patient with postoperative CoV-2 infection. BMJ Case Reports 14:8, pages e243744.
Crossref
Maryam Bayat, Yahya Asemani & Sajad Najafi. (2021) Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. International Immunopharmacology 97, pages 107679.
Crossref
Zitong Feng, Juan Yang, Mingzhu Xu, Run Lin, Huijun Yang, Liting Lai, Yixiao Wang, Dietlind L. Wahner-Roedler, Xuan Zhou, Kyung-Min Shin, Manisha Salinas, Molly J. Mallory, Chunzhi Tang, David C. Patchett, Brent A. Bauer & Shaoyang Cui. (2021) Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials. Clinical Nutrition ESPEN 44, pages 50-60.
Crossref
Seda Kahraman, Muhammed Bulent Akinci, Mehmet Ali Nahit Sendur & Bulent Yalcin. (2021) Can the host immune response against SARS-CoV2 also cause an anticancer effect?. Medical Oncology 38:8.
Crossref
Zeba Firdaus, Sushil Kumar Singh, Tryambak Deo Singh & Meenakshi Singh. (2021) The scientific community in COVID-19 global pandemic: A systematic update on recent progress and challenges. European Journal of Chemistry 12:2, pages 222-234.
Crossref
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas & Jean-Charles Soria. (2021) Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19. Cancer Discovery 11:6, pages 1336-1344.
Crossref
Joanna Kulikowska, Agnieszka Kulczyńska-Przybik, Barbara Mroczko & Alina Kułakowska. (2021) The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review. International Journal of Molecular Sciences 22:11, pages 5894.
Crossref
Liangjian Lu, Chee Teck Koh, Yi Herng Lim, Andrew Sng, Kok Siong Poon, Shaun S Y Tan, Pao Tang Kao, Nancy Tee, Hui Kim Yap, Bee Wah Lee & Paul A Tambyah. (2021) Role of Asymptomatic Children in Community Severe Acute Respiratory Syndrome Coronavirus 2 Transmission. The Journal of Infectious Diseases 223:10, pages 1834-1836.
Crossref
Luca Occhigrossi, Federica Rossin, Manuela D’Eletto, Maria Grazia Farrace, Fabiola Ciccosanti, Linda Petrone, Alessandra Sacchi, Roberta Nardacci, Laura Falasca, Franca Del Nonno, Ivana Palucci, Evgeni Smirnov, Nick Barlev, Chiara Agrati, Delia Goletti, Giovanni Delogu, Gian Maria Fimia & Mauro Piacentini. (2021) Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis. The Journal of Immunology 206:10, pages 2420-2429.
Crossref
Tsvetelina Velikova. (2021) INFECTION-ACQUIRED VERSUS VACCINE-INDUCED IMMUNITY AGAINST COVID-19. Central Asian Journal of Medical Hypotheses and Ethics 2:1, pages 29-35.
Crossref
Arezoo Beig Parikhani, Masoume Bazaz, Hadi Bamehr, Sepideh Fereshteh, Shahin Amiri, Mostafa Salehi-Vaziri, Arash Arashkia & Kayhan Azadmanesh. (2021) The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options. Current Microbiology 78:4, pages 1099-1114.
Crossref
Paola Iaccarino Idelson, Domenico Rendina & Pasquale Strazzullo. (2021) Nutrition and the Covid-19 pandemic: Three factors with high impact on community health. Nutrition, Metabolism and Cardiovascular Diseases 31:3, pages 756-761.
Crossref
Engin Berber, Deepak Sumbria & Barry T. Rouse. (2021) Could targeting immunometabolism be a way to control the burden of COVID-19 infection?. Microbes and Infection 23:2-3, pages 104780.
Crossref
Nufar Marcus, Shirly Frizinsky, David Hagin, Adi Ovadia, Suhair Hanna, Michael Farkash, Ramit Maoz-Segal, Nancy Agmon-Levin, Arnon Broides, Amit Nahum, Elli Rosenberg, Amir Asher Kuperman, Yael Dinur-Schejter, Yackov Berkun, Ori Toker, Shmuel Goldberg, Ronit Confino-Cohen, Oded Scheuerman, Basel Badarneh, Na‘ama Epstein-Rigbi, Amos Etzioni, Ilan Dalal & Raz Somech. (2021) Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel. Frontiers in Immunology 11.
Crossref
Ronald N. Kostoff, Daniela Calina, Darja Kanduc, Michael B. Briggs, Panayiotis Vlachoyiannopoulos, Andrey A. Svistunov & Aristidis Tsatsakis. (2021) RETRACTED: Why are we vaccinating children against COVID-19?. Toxicology Reports 8, pages 1665-1684.
Crossref
U. Muscha Steckelings & Colin Sumners. (2020) Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clinical Science 134:22, pages 2987-3006.
Crossref
Stefan Pilz, Verena Theiler-Schwetz, Christian Trummer, Robert Krause & John P. A. Ioannidis. (2022) SARS-CoV-2 Reinfections: Overview of Efficacy and Duration of Natural and Hybrid Immunity. SSRN Electronic Journal.
Crossref
Pierre Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Tredan, Thomas Bachelot, Isabelle-Laure Ray-Coquard, Bruno Russias, Marie-Line Fournier, Benedicte Mastroianni, Virginie Avrillon, Anne-Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol & Jean-Yves Blay. (2021) Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.